Clinical Trial Update: Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 trial to assess pharmacokinetics, efficacy, and safety of twice-daily hydroxycarbamide dispersible tablets in children with sickle cell disease; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Hydroxycarbamide Dispersible Tablets (hydroxycarbamide)

Snippet

Sponsor: Theravia | Conditions: Sickle Cell Disease | Phase 2 | Status: RECRUITING